Herpes simplex infection in a patient with rheumatoid arthritis treated with baricitinib: a case report-Reference-Cited by-同舟云学术

Herpes simplex infection in a patient with rheumatoid arthritis treated with baricitinib: a case report

Published:2020-11-03 Issue:4 Volume:60 Page:e122-e123
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Valor-Méndez Larissa¹²,Voskens Caroline²³,Rech Jürgen¹²,Kleyer Arnd¹²,Schett Georg ¹²

Affiliation:

1. Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany

2. Deutsches Zentrum für Immuntherapie (DZI), Friedrich Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany

3. Department of Dermatology, Friedrich Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/60/4/e122/36912987/keaa521.pdf

Reference8 articles.

1. The effect of JAK1/JAK2 inhibition in rheumatoid arthritis: efficacy and safety of baricitinib;Choy;Clin Exp Rheumatol,2019

2. The neurotropic herpes viruses: herpes simplex and varicella-zoster;Steiner;Lancet Neurol,2007

3. Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis;Widdifield;Arthritis Care Res,2013

4. Disseminated cutaneous Herpes Simplex Virus-1 in a woman with rheumatoid arthritis receiving infliximab: a case report;Justice;J Med Case Rep,2008

5. Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy;Yun;Arthritis Care Res,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct oral DNA viral signatures in rheumatoid arthritis: a Pilot study;Journal of Oral Microbiology;2024-05

2. Human autoantibodies neutralizing type I IFNs: From 1981 to 2023;Immunological Reviews;2024-01-09

3. Current application status and structure–activity relationship of selective and non-selective JAK inhibitors in diseases;International Immunopharmacology;2023-09

4. Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease;PLOS Biology;2022-07-05

5. Herpesvirus Reactivations in Critically-Ill COVID-19 Patients with Autoantibodies Neutralizing Type I Interferons;2022-03-21